Figure 4From: Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study Correlations between studied variables and recurrent tumor size in patients who underwent TACE. (a) Pre-treatment serum AFP level (AFPT0) and recurrent tumor size (RTS) were not correlated (r = 0.371, P > 0.05). (b) Recurrent tumor size (TST0) and RTS were not correlated (r = 0.190, P > 0.05). (c) The 3-month post-treatment serum level (AFTT3) and RTS were not correlated (r = 0.273, P > 0.05).Back to article page